Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Charles Q. Harrold"'
Autor:
Bryan P, Fitzgerald, Charles E, Hawley, Charles Q, Harrold, J Steven, Garrett, Alan M, Polson, Thomas E, Rams
Publikováno v:
Journal of Oral Biology. 8
Clinical standardization and calibration training is recommended to increase the reproducibility of periodontal probing, but its impact on manual periodontal probing outcomes has received little attention. This study examined the reproducibility of m
Autor:
Steve Garrett, Lonnie R. Johnson, Norman H. Stoller, Mark I. Ryder, Charles Q. Harrold, Alan M. Polson
Publikováno v:
Journal of Clinical Periodontology. 29:87-91
Les effets du tartre sous-gingival sur les comportements cliniques de l'application locale de doxycycline a liberation controlee par comparaison avec le detartrage/surfacage radiculaire Origine, but: Les effets du tartre sous-gingival sur les comport
Autor:
Vladimir W. Spolsky, R. Lamont MacNeil, Frank J. Raab, Lonnie R. Johnson, Donald H. Newell, Steven Garrett, Charles Q. Harrold, Bradley Beiswanger, Norman H. Stoller, Lawrence E. Wolinsky, William W. Hallmon, Bryan Fitzgerald, Hom-Lay Wang, James T. Mellonig, David F. Atack, Alan M. Polson, G. Lee Southard, Margaret Hill, Ralph M. Arnold, William J. Killoy, Anne P. Polson, Kevin J. Donly, Donald F. Adams, Gerald H. Evans, Philip J. Hanes, Hisham F. Nasi, Mark I. Ryder, Susan P. Duke, Gary Bogle, E. Brady Hancock, Connie Hastings Drisko, Robert Kiger, Carl L. Bandt, R.L. Isaacs, Charles E. Hawley, Simon R. MacNeill
Publikováno v:
Journal of Periodontology. 70:490-503
The clinical efficacy and safety of doxycycline hyclate (8.5% w/w) delivered subgingivally in a biodegradable polymer (DH) was compared to placebo control (VC), oral hygiene (OH), and scaling and root planing (SRP) in 2 multi-center studies.Each stud
Publikováno v:
Journal of Periodontology. 69:1085-1091
The primary goal of this study was to characterize the release profile of doxycycline hyclate (8.5% w/w) from a biodegradable controlled-release delivery system (DH) placed in periodontal pockets. Pharmacokinetic data were obtained from gingival crev
Autor:
Charles Q. Harrold, Philip J. Hanes, Susan P. Duke, Carl L. Bandt, Steven Garrett, William J. Killoy, Alan M. Polson, G. Lee Southard, Norman H. Stoller
Publikováno v:
Journal of Periodontology. 68:110-118
The design and conduct of a 9-month multi-center clinical trial to evaluate the safety and efficacy of subgingivally delivered 5% sanguinarium chloride (SC) and 10% doxycycline hyclate (DH) from a biodegradable drug delivery system in the treatment o
Autor:
Lonnie R, Johnson, Norman H, Stoller, Alan, Polson, Charles Q, Harrold, Mark, Ryder, Steve, Garrett
Publikováno v:
Journal of clinical periodontology. 29(2)
The effect of subgingival calculus on the clinical outcomes of the local delivery of antimicrobials is unknown. This study examines the clinical outcomes of treatment with locally delivered controlled-release doxycycline (DH) or scaling and root plan
Autor:
Charles Q. Harrold, Margaret Hill, Lawrence E. Wolinsky, William W. Hallmon, Horn Lay Wang, Robert Kiger, G. Lee Southard, Connie Hastings Drisko, Alan M. Polson, Philip J. Hanes, William J. Killoy, Steven Garrett, Norman H. Stoller, Frank J. Raab, Kevin J. Donly, Donald F. Adams, James T. Mellonig, Gary Bogle, E. Brady Hancock, Raymond A. Yukna, Lonnie R. Johnson, Charles E. Hawley, Valerie Blanco Johnson, Mark I. Ryder
Publikováno v:
Journal of periodontology. 71(1)
This research report evaluates clinical changes resulting from local delivery of doxycycline hyclate (DH) or traditional scaling and root planing (SRP) in a group of patients undergoing supportive periodontal therapy (SPT).In all, 141 patients receiv
Autor:
Henry Greenwell, Jack G. Caton, Steven Garrett, Connie Drisko, Roxanne A. Lowenguth, Timothy A. DeRouen, Susan P. Duke, Charles Q. Harrold, Norman H. Stoller, Alan M. Polson, Gary Bogle
Publikováno v:
Journal of periodontology. 68(7)
This multi-center single-blind study compared clinical outcomes following guided tissue regeneration (GTR) treating human Class II furcation defects with a new polylactic-acid-based bioabsorbable barrier (test treatment) or a non-absorbable ePTFE bar